The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity
Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not...
Uloženo v:
| Vydáno v: | Nutrients Ročník 15; číslo 4; s. 825 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Switzerland
MDPI AG
06.02.2023
MDPI |
| Témata: | |
| ISSN: | 2072-6643, 2072-6643 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not take any drugs. This prospective, real-life study included thirty-three participants who followed a VLCKD for 8 weeks. NAFLD was diagnosed using transient elastography (FibroScan). Data on anthropometric measurements, bioimpedance analysis, and biochemical assays were gathered both before and after the dietary intervention. BMI (kg/m2) (from 33.84 ± 6.55 to 30.89 ± 6.38, p < 0.01), waist circumference (cm) (from 106.67 ± 15.51 to 98.64 ± 16.21, p < 0.01), and fat mass (Kg) (from 38.47 ± 12.59 to 30.98 ± 12.39, p < 0.01) were significantly lower after VLCKD. CAP (db/m), the FibroScan parameter quantifying fatty liver accumulation, showed a significant reduction after VLCKD (from 266.61 ± 67.96 to 223 ± 64.19, p < 0.01). After VLCKD, the fatty liver index (FLI), a benchmark of steatosis, also revealed a significant decline (from 62.82 ± 27.46 to 44.09 ± 31.24, p < 0.01). Moreover, fasting blood glucose, insulin, triglycerides, total cholesterol, LDL-cholesterol, ALT, γGT, and FT3 blood concentrations, as well as insulin resistance (quantified by HOMAIR) and systolic and diastolic blood pressure levels, were significantly lower after VLCKD (p < 0.01 for all the parameters). By contrast, HDL-cholesterol, 25 (OH) vitamin D, and FT4 blood concentrations were higher after VLCKD (p < 0.01 for all parameters). The variation (δ) of CAP after VLCKD did not show a correlation with the δ of any other parameter investigated in this study. We conclude that VLCKD is a helpful approach for NAFLD independent of changes in factors commonly associated with NAFLD (obesity, fat mass, insulin resistance, lipids, and blood pressure) as well as vitamin D and thyroid hormone levels. |
|---|---|
| AbstractList | Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not take any drugs. This prospective, real-life study included thirty-three participants who followed a VLCKD for 8 weeks. NAFLD was diagnosed using transient elastography (FibroScan). Data on anthropometric measurements, bioimpedance analysis, and biochemical assays were gathered both before and after the dietary intervention. BMI (kg/m2) (from 33.84 ± 6.55 to 30.89 ± 6.38, p < 0.01), waist circumference (cm) (from 106.67 ± 15.51 to 98.64 ± 16.21, p < 0.01), and fat mass (Kg) (from 38.47 ± 12.59 to 30.98 ± 12.39, p < 0.01) were significantly lower after VLCKD. CAP (db/m), the FibroScan parameter quantifying fatty liver accumulation, showed a significant reduction after VLCKD (from 266.61 ± 67.96 to 223 ± 64.19, p < 0.01). After VLCKD, the fatty liver index (FLI), a benchmark of steatosis, also revealed a significant decline (from 62.82 ± 27.46 to 44.09 ± 31.24, p < 0.01). Moreover, fasting blood glucose, insulin, triglycerides, total cholesterol, LDL-cholesterol, ALT, γGT, and FT3 blood concentrations, as well as insulin resistance (quantified by HOMAIR) and systolic and diastolic blood pressure levels, were significantly lower after VLCKD (p < 0.01 for all the parameters). By contrast, HDL-cholesterol, 25 (OH) vitamin D, and FT4 blood concentrations were higher after VLCKD (p < 0.01 for all parameters). The variation (δ) of CAP after VLCKD did not show a correlation with the δ of any other parameter investigated in this study. We conclude that VLCKD is a helpful approach for NAFLD independent of changes in factors commonly associated with NAFLD (obesity, fat mass, insulin resistance, lipids, and blood pressure) as well as vitamin D and thyroid hormone levels. Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not take any drugs. This prospective, real-life study included thirty-three participants who followed a VLCKD for 8 weeks. NAFLD was diagnosed using transient elastography (FibroScan). Data on anthropometric measurements, bioimpedance analysis, and biochemical assays were gathered both before and after the dietary intervention. BMI (kg/m ) (from 33.84 ± 6.55 to 30.89 ± 6.38, < 0.01), waist circumference (cm) (from 106.67 ± 15.51 to 98.64 ± 16.21, < 0.01), and fat mass (Kg) (from 38.47 ± 12.59 to 30.98 ± 12.39, < 0.01) were significantly lower after VLCKD. CAP (db/m), the FibroScan parameter quantifying fatty liver accumulation, showed a significant reduction after VLCKD (from 266.61 ± 67.96 to 223 ± 64.19, < 0.01). After VLCKD, the fatty liver index (FLI), a benchmark of steatosis, also revealed a significant decline (from 62.82 ± 27.46 to 44.09 ± 31.24, < 0.01). Moreover, fasting blood glucose, insulin, triglycerides, total cholesterol, LDL-cholesterol, ALT, γGT, and FT3 blood concentrations, as well as insulin resistance (quantified by HOMAIR) and systolic and diastolic blood pressure levels, were significantly lower after VLCKD ( < 0.01 for all the parameters). By contrast, HDL-cholesterol, 25 (OH) vitamin D, and FT4 blood concentrations were higher after VLCKD ( < 0.01 for all parameters). The variation (δ) of CAP after VLCKD did not show a correlation with the δ of any other parameter investigated in this study. We conclude that VLCKD is a helpful approach for NAFLD independent of changes in factors commonly associated with NAFLD (obesity, fat mass, insulin resistance, lipids, and blood pressure) as well as vitamin D and thyroid hormone levels. Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not take any drugs. This prospective, real-life study included thirty-three participants who followed a VLCKD for 8 weeks. NAFLD was diagnosed using transient elastography (FibroScan). Data on anthropometric measurements, bioimpedance analysis, and biochemical assays were gathered both before and after the dietary intervention. BMI (kg/m²) (from 33.84 ± 6.55 to 30.89 ± 6.38, p < 0.01), waist circumference (cm) (from 106.67 ± 15.51 to 98.64 ± 16.21, p < 0.01), and fat mass (Kg) (from 38.47 ± 12.59 to 30.98 ± 12.39, p < 0.01) were significantly lower after VLCKD. CAP (db/m), the FibroScan parameter quantifying fatty liver accumulation, showed a significant reduction after VLCKD (from 266.61 ± 67.96 to 223 ± 64.19, p < 0.01). After VLCKD, the fatty liver index (FLI), a benchmark of steatosis, also revealed a significant decline (from 62.82 ± 27.46 to 44.09 ± 31.24, p < 0.01). Moreover, fasting blood glucose, insulin, triglycerides, total cholesterol, LDL-cholesterol, ALT, γGT, and FT3 blood concentrations, as well as insulin resistance (quantified by HOMAIR) and systolic and diastolic blood pressure levels, were significantly lower after VLCKD (p < 0.01 for all the parameters). By contrast, HDL-cholesterol, 25 (OH) vitamin D, and FT4 blood concentrations were higher after VLCKD (p < 0.01 for all parameters). The variation (δ) of CAP after VLCKD did not show a correlation with the δ of any other parameter investigated in this study. We conclude that VLCKD is a helpful approach for NAFLD independent of changes in factors commonly associated with NAFLD (obesity, fat mass, insulin resistance, lipids, and blood pressure) as well as vitamin D and thyroid hormone levels. Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not take any drugs. This prospective, real-life study included thirty-three participants who followed a VLCKD for 8 weeks. NAFLD was diagnosed using transient elastography (FibroScan). Data on anthropometric measurements, bioimpedance analysis, and biochemical assays were gathered both before and after the dietary intervention. BMI (kg/m[sup.2]) (from 33.84 ± 6.55 to 30.89 ± 6.38, p < 0.01), waist circumference (cm) (from 106.67 ± 15.51 to 98.64 ± 16.21, p < 0.01), and fat mass (Kg) (from 38.47 ± 12.59 to 30.98 ± 12.39, p < 0.01) were significantly lower after VLCKD. CAP (db/m), the FibroScan parameter quantifying fatty liver accumulation, showed a significant reduction after VLCKD (from 266.61 ± 67.96 to 223 ± 64.19, p < 0.01). After VLCKD, the fatty liver index (FLI), a benchmark of steatosis, also revealed a significant decline (from 62.82 ± 27.46 to 44.09 ± 31.24, p < 0.01). Moreover, fasting blood glucose, insulin, triglycerides, total cholesterol, LDL-cholesterol, ALT, γGT, and FT3 blood concentrations, as well as insulin resistance (quantified by HOMAIR) and systolic and diastolic blood pressure levels, were significantly lower after VLCKD (p < 0.01 for all the parameters). By contrast, HDL-cholesterol, 25 (OH) vitamin D, and FT4 blood concentrations were higher after VLCKD (p < 0.01 for all parameters). The variation (δ) of CAP after VLCKD did not show a correlation with the δ of any other parameter investigated in this study. We conclude that VLCKD is a helpful approach for NAFLD independent of changes in factors commonly associated with NAFLD (obesity, fat mass, insulin resistance, lipids, and blood pressure) as well as vitamin D and thyroid hormone levels. Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not take any drugs. This prospective, real-life study included thirty-three participants who followed a VLCKD for 8 weeks. NAFLD was diagnosed using transient elastography (FibroScan). Data on anthropometric measurements, bioimpedance analysis, and biochemical assays were gathered both before and after the dietary intervention. BMI (kg/m2) (from 33.84 ± 6.55 to 30.89 ± 6.38, p < 0.01), waist circumference (cm) (from 106.67 ± 15.51 to 98.64 ± 16.21, p < 0.01), and fat mass (Kg) (from 38.47 ± 12.59 to 30.98 ± 12.39, p < 0.01) were significantly lower after VLCKD. CAP (db/m), the FibroScan parameter quantifying fatty liver accumulation, showed a significant reduction after VLCKD (from 266.61 ± 67.96 to 223 ± 64.19, p < 0.01). After VLCKD, the fatty liver index (FLI), a benchmark of steatosis, also revealed a significant decline (from 62.82 ± 27.46 to 44.09 ± 31.24, p < 0.01). Moreover, fasting blood glucose, insulin, triglycerides, total cholesterol, LDL-cholesterol, ALT, γGT, and FT3 blood concentrations, as well as insulin resistance (quantified by HOMAIR) and systolic and diastolic blood pressure levels, were significantly lower after VLCKD (p < 0.01 for all the parameters). By contrast, HDL-cholesterol, 25 (OH) vitamin D, and FT4 blood concentrations were higher after VLCKD (p < 0.01 for all parameters). The variation (δ) of CAP after VLCKD did not show a correlation with the δ of any other parameter investigated in this study. We conclude that VLCKD is a helpful approach for NAFLD independent of changes in factors commonly associated with NAFLD (obesity, fat mass, insulin resistance, lipids, and blood pressure) as well as vitamin D and thyroid hormone levels.Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not take any drugs. This prospective, real-life study included thirty-three participants who followed a VLCKD for 8 weeks. NAFLD was diagnosed using transient elastography (FibroScan). Data on anthropometric measurements, bioimpedance analysis, and biochemical assays were gathered both before and after the dietary intervention. BMI (kg/m2) (from 33.84 ± 6.55 to 30.89 ± 6.38, p < 0.01), waist circumference (cm) (from 106.67 ± 15.51 to 98.64 ± 16.21, p < 0.01), and fat mass (Kg) (from 38.47 ± 12.59 to 30.98 ± 12.39, p < 0.01) were significantly lower after VLCKD. CAP (db/m), the FibroScan parameter quantifying fatty liver accumulation, showed a significant reduction after VLCKD (from 266.61 ± 67.96 to 223 ± 64.19, p < 0.01). After VLCKD, the fatty liver index (FLI), a benchmark of steatosis, also revealed a significant decline (from 62.82 ± 27.46 to 44.09 ± 31.24, p < 0.01). Moreover, fasting blood glucose, insulin, triglycerides, total cholesterol, LDL-cholesterol, ALT, γGT, and FT3 blood concentrations, as well as insulin resistance (quantified by HOMAIR) and systolic and diastolic blood pressure levels, were significantly lower after VLCKD (p < 0.01 for all the parameters). By contrast, HDL-cholesterol, 25 (OH) vitamin D, and FT4 blood concentrations were higher after VLCKD (p < 0.01 for all parameters). The variation (δ) of CAP after VLCKD did not show a correlation with the δ of any other parameter investigated in this study. We conclude that VLCKD is a helpful approach for NAFLD independent of changes in factors commonly associated with NAFLD (obesity, fat mass, insulin resistance, lipids, and blood pressure) as well as vitamin D and thyroid hormone levels. |
| Audience | Academic |
| Author | Castellana, Fabio Triggiani, Vincenzo Lampignano, Luisa Giannuzzi, Vito Di Chito, Martina Shahini, Endrit Rinaldi, Roberta Cozzolongo, Raffaele De Nucci, Sara Giannelli, Gianluigi De Pergola, Giovanni Zupo, Roberta Piazzolla, Giuseppina |
| AuthorAffiliation | 4 Interdisciplinary Department of Medicine, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare 11, 70124 Bari, Italy 3 Department of Gastroenterology, National Institute of Gastroenterology “Saverio de Bellis”, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy 5 Scientific Direction, National Institute of Gastroenterology “Saverio de Bellis”, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy 1 Unit of Geriatrics and Internal Medicine, National Institute of Gastroenterology “Saverio de Bellis”, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy 2 Unit of Data Sciences and Technology Innovation for Population Health, National Institute of Gastroenterology “Saverio de Bellis”, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy |
| AuthorAffiliation_xml | – name: 1 Unit of Geriatrics and Internal Medicine, National Institute of Gastroenterology “Saverio de Bellis”, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy – name: 4 Interdisciplinary Department of Medicine, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare 11, 70124 Bari, Italy – name: 2 Unit of Data Sciences and Technology Innovation for Population Health, National Institute of Gastroenterology “Saverio de Bellis”, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy – name: 3 Department of Gastroenterology, National Institute of Gastroenterology “Saverio de Bellis”, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy – name: 5 Scientific Direction, National Institute of Gastroenterology “Saverio de Bellis”, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy |
| Author_xml | – sequence: 1 givenname: Roberta orcidid: 0000-0002-3817-8643 surname: Rinaldi fullname: Rinaldi, Roberta – sequence: 2 givenname: Sara surname: De Nucci fullname: De Nucci, Sara – sequence: 3 givenname: Fabio orcidid: 0000-0002-6439-8228 surname: Castellana fullname: Castellana, Fabio – sequence: 4 givenname: Martina surname: Di Chito fullname: Di Chito, Martina – sequence: 5 givenname: Vito surname: Giannuzzi fullname: Giannuzzi, Vito – sequence: 6 givenname: Endrit orcidid: 0000-0002-4909-0436 surname: Shahini fullname: Shahini, Endrit – sequence: 7 givenname: Roberta orcidid: 0000-0001-9885-1185 surname: Zupo fullname: Zupo, Roberta – sequence: 8 givenname: Luisa orcidid: 0000-0001-9299-3211 surname: Lampignano fullname: Lampignano, Luisa – sequence: 9 givenname: Giuseppina orcidid: 0000-0003-3221-6562 surname: Piazzolla fullname: Piazzolla, Giuseppina – sequence: 10 givenname: Vincenzo orcidid: 0000-0001-6308-0528 surname: Triggiani fullname: Triggiani, Vincenzo – sequence: 11 givenname: Raffaele surname: Cozzolongo fullname: Cozzolongo, Raffaele – sequence: 12 givenname: Gianluigi surname: Giannelli fullname: Giannelli, Gianluigi – sequence: 13 givenname: Giovanni surname: De Pergola fullname: De Pergola, Giovanni |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36839183$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFks1uEzEUhS1UREvohgdAltgUpBT_ZOzxBilKA0UdKQuisrQ8njuJw8QuM55W2bHgJXg9ngQnLf1TJWxZtuzvHlvH5yXa88EDQq8pOeZckQ--pxkZkZxlz9ABI5INhRjxvXvrfXTYdSuybZJIwV-gfS5yrmjOD9Cv-RLwtK7Bxg6HGk_dYhnxN4Dv3Z-fv_E5tBtchKvhxDShdYDPIIYFeGfxiYOIj86LydnJOxw8LtwltPgUTBOX2Hn8tS9XO9XxTh0qXG7wLDFXsLvD-ArPSuhc3LxCz2vTdHB4Mw_Q_NN0PjkdFrPPXybjYmgzIuJQlUqWlEpREqWAkVpRaRjlLCPAWE5qYWnJVQ6EMpvxnFBqKlJWUGaG8JoP0Mdr2Yu-XENlwcfWNPqidWvTbnQwTj888W6pF-FSKyWYGKkkcHQj0IYfPXRRr11noWmMh9B3mqePSPczSf6LMpkTIkQmRELfPkJXoW99MiJRUgnKM5nfUQvTgHa-DumJdiuqx3KUPOAqjQE6foJKvYK1syk5tUv7Dwre3Pfk1ox_CUnA-2vAtqHrWqhvEUr0NoH6LoEJJo9g66KJLmz9dM1TJX8BminaJA |
| CitedBy_id | crossref_primary_10_1007_s13679_024_00573_0 crossref_primary_10_3390_jcm13164857 crossref_primary_10_3390_nu16101408 crossref_primary_10_3390_nu16060874 crossref_primary_10_2196_60051 crossref_primary_10_3390_biomedicines13010217 crossref_primary_10_1186_s12872_025_04666_z crossref_primary_10_1038_s41387_025_00391_w crossref_primary_10_3390_nu16234161 crossref_primary_10_3390_nu17010072 crossref_primary_10_1007_s13668_024_00528_w crossref_primary_10_3390_nu15234931 crossref_primary_10_3390_nu15173752 crossref_primary_10_3390_nu16234189 crossref_primary_10_1210_clinem_dgaf196 crossref_primary_10_3390_nu15153368 crossref_primary_10_3390_nu15112619 crossref_primary_10_1016_j_jafr_2025_101981 crossref_primary_10_3390_ijms25042251 crossref_primary_10_3390_nu16152386 crossref_primary_10_1007_s13679_025_00622_2 crossref_primary_10_3390_nu15184027 crossref_primary_10_3390_nu15204468 crossref_primary_10_3390_ijms25137076 crossref_primary_10_1016_j_advnut_2025_100375 crossref_primary_10_1016_j_yjcafi_2025_07_004 crossref_primary_10_3390_nu15112561 crossref_primary_10_3390_nu17071269 crossref_primary_10_1016_j_nut_2024_112480 crossref_primary_10_1007_s13668_024_00556_6 |
| Cites_doi | 10.3390/jcm10081695 10.1053/j.gastro.2019.01.042 10.3390/biomedicines8020028 10.21037/hbsn-20-787 10.3748/wjg.v24.i30.3361 10.1186/s12967-021-03221-6 10.1007/BF00280883 10.1038/s41575-020-00381-6 10.1016/j.clnesp.2019.09.012 10.1002/hep.29367 10.1016/j.cgh.2021.12.002 10.3389/fnut.2022.1002669 10.1073/pnas.1922344117 10.1038/s41395-018-0088-6 10.3390/nu12020333 10.1097/MCO.0000000000000762 10.2174/1574887109666141216101630 10.3390/nu12072141 10.3390/jcm10091877 10.3389/fendo.2020.00607 10.1186/s13098-020-00570-y 10.1007/s40618-019-01061-2 10.21037/tgh.2019.09.08 10.1038/s41598-021-03583-3 10.1053/j.gastro.2018.12.036 10.1111/obr.13024 10.1186/1471-230X-6-33 10.3390/nu13061804 10.1080/07315724.1992.12098245 10.1016/j.jhep.2015.11.004 10.1159/000515381 10.1093/clinchem/36.1.15 10.3390/ijms21165888 10.1016/j.numecd.2008.10.007 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2023 MDPI AG 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 by the authors. 2023 |
| Copyright_xml | – notice: COPYRIGHT 2023 MDPI AG – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 by the authors. 2023 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TS 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7S9 L.6 5PM |
| DOI | 10.3390/nu15040825 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Physical Education Index ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE CrossRef AGRICOLA Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 2072-6643 |
| ExternalDocumentID | PMC9962649 A743253925 36839183 10_3390_nu15040825 |
| Genre | Journal Article |
| GeographicLocations | Italy |
| GeographicLocations_xml | – name: Italy |
| GrantInformation_xml | – fundername: Italian Ministry of Health with Ricerca Corrente 2021 funds |
| GroupedDBID | --- 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAWTL AAYXX ABUWG ACIWK ACPRK AENEX AFFHD AFKRA AFRAH AFZYC ALMA_UNASSIGNED_HOLDINGS APEBS BENPR BPHCQ BVXVI CCPQU CITATION DIK E3Z EBD ECGQY EIHBH ESTFP EYRJQ F5P FYUFA GX1 HMCUK HYE IAO ITC KQ8 LK8 M1P M48 MODMG M~E OK1 OZF P2P P6G PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO RNS RPM TR2 UKHRP 3V. ALIPV ATCPS BBNVY BHPHI CGR CUY CVF ECM EIF GROUPED_DOAJ HCIFZ M0K M7P NPM 7TS 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 7S9 L.6 PUEGO 5PM |
| ID | FETCH-LOGICAL-c506t-9b97b1176b099e20f917a213250e2280f6c1b398e012c538011ad0bdeb5a03f3 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 29 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000941012400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2072-6643 |
| IngestDate | Tue Nov 04 02:06:32 EST 2025 Thu Oct 02 10:29:39 EDT 2025 Sun Nov 09 11:49:12 EST 2025 Tue Oct 07 07:20:56 EDT 2025 Tue Nov 11 11:14:05 EST 2025 Tue Nov 04 18:41:45 EST 2025 Thu Jan 02 22:53:03 EST 2025 Tue Nov 18 21:12:17 EST 2025 Sat Nov 29 07:15:35 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | non-alcoholic fatty liver disease (NAFLD) transient elastography (FibroScan) very low calorie ketogenic diet (VLCKD) insulin resistance obesity |
| Language | English |
| License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c506t-9b97b1176b099e20f917a213250e2280f6c1b398e012c538011ad0bdeb5a03f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work. |
| ORCID | 0000-0002-3817-8643 0000-0001-6308-0528 0000-0002-6439-8228 0000-0003-3221-6562 0000-0001-9885-1185 0000-0002-4909-0436 0000-0001-9299-3211 |
| OpenAccessLink | https://www.proquest.com/docview/2779613578?pq-origsite=%requestingapplication% |
| PMID | 36839183 |
| PQID | 2779613578 |
| PQPubID | 2032353 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9962649 proquest_miscellaneous_3040398270 proquest_miscellaneous_2780066566 proquest_journals_2779613578 gale_infotracmisc_A743253925 gale_infotracacademiconefile_A743253925 pubmed_primary_36839183 crossref_primary_10_3390_nu15040825 crossref_citationtrail_10_3390_nu15040825 |
| PublicationCentury | 2000 |
| PublicationDate | 20230206 |
| PublicationDateYYYYMMDD | 2023-02-06 |
| PublicationDate_xml | – month: 2 year: 2023 text: 20230206 day: 6 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | Nutrients |
| PublicationTitleAlternate | Nutrients |
| PublicationYear | 2023 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Noureddin (ref_14) 2018; 113 Le (ref_1) 2021; 20 Valerio (ref_4) 2020; 12 Muscogiuri (ref_20) 2021; 14 ref_36 ref_35 Babio (ref_27) 2009; 19 ref_16 Castera (ref_17) 2019; 156 Beaudart (ref_28) 2020; 35 ref_15 Eddowes (ref_18) 2019; 156 Watanabe (ref_24) 2020; 21 Risi (ref_33) 2021; 24 Berzigotti (ref_32) 2014; 9 Warnick (ref_30) 1990; 36 Matthews (ref_31) 1985; 28 Cholongitas (ref_2) 2021; 34 Chalasani (ref_10) 2018; 67 Luukkonen (ref_37) 2020; 117 Caprio (ref_23) 2019; 42 Barrea (ref_21) 2022; 20 Castellana (ref_7) 2022; 9 ref_22 Huang (ref_13) 2021; 18 Nseir (ref_19) 2014; 20 Marchesini (ref_11) 2016; 64 Mitra (ref_5) 2020; 5 ref_3 Kushner (ref_29) 1992; 11 ref_26 ref_8 Castellana (ref_9) 2021; 11 Cunha (ref_25) 2020; 11 Eilenberg (ref_34) 2021; 10 Leoni (ref_12) 2018; 24 ref_6 |
| References_xml | – volume: 20 start-page: 9338 year: 2014 ident: ref_19 article-title: Role of diet and lifestyle changes in nonalcoholic fatty liver disease publication-title: World J. Gastroenterol. – volume: 34 start-page: 404 year: 2021 ident: ref_2 article-title: Epidemiology of nonalcoholic fatty liver disease in Europe: A systematic review and meta-analysis publication-title: Ann. Gastroenterol. – ident: ref_26 – ident: ref_8 doi: 10.3390/jcm10081695 – volume: 156 start-page: 1717 year: 2019 ident: ref_18 article-title: Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.01.042 – ident: ref_6 doi: 10.3390/biomedicines8020028 – volume: 10 start-page: 610 year: 2021 ident: ref_34 article-title: Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity publication-title: HepatoBiliary Surg. Nutr. doi: 10.21037/hbsn-20-787 – volume: 24 start-page: 3361 year: 2018 ident: ref_12 article-title: Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v24.i30.3361 – volume: 20 start-page: 23 year: 2022 ident: ref_21 article-title: VLCKD: A real time safety study in obesity publication-title: J. Transl. Med. doi: 10.1186/s12967-021-03221-6 – volume: 28 start-page: 412 year: 1985 ident: ref_31 article-title: Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 18 start-page: 223 year: 2021 ident: ref_13 article-title: Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-020-00381-6 – volume: 35 start-page: 47 year: 2020 ident: ref_28 article-title: Equation models developed with bioelectric impedance analysis tools to assess muscle mass: A systematic review publication-title: Clin. Nutr. ESPEN doi: 10.1016/j.clnesp.2019.09.012 – volume: 67 start-page: 328 year: 2018 ident: ref_10 article-title: The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases publication-title: Hepatology doi: 10.1002/hep.29367 – volume: 20 start-page: 2809 year: 2021 ident: ref_1 article-title: 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2021.12.002 – volume: 9 start-page: 1002669 year: 2022 ident: ref_7 article-title: Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity publication-title: Front. Nutr. doi: 10.3389/fnut.2022.1002669 – volume: 117 start-page: 7347 year: 2020 ident: ref_37 article-title: Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1922344117 – volume: 113 start-page: 1649 year: 2018 ident: ref_14 article-title: NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances publication-title: Am. J. Gastroenterol. doi: 10.1038/s41395-018-0088-6 – ident: ref_22 doi: 10.3390/nu12020333 – volume: 24 start-page: 349 year: 2021 ident: ref_33 article-title: Beyond weight loss in nonalcoholic fatty liver disease: The role of carbohydrate restriction publication-title: Curr. Opin. Clin. Nutr. Metab. Care doi: 10.1097/MCO.0000000000000762 – volume: 9 start-page: 170 year: 2014 ident: ref_32 article-title: Non-invasive assessment of non-alcoholic fatty liver disease: Ultrasound and transient elastography publication-title: Rev. Recent Clin. Trials doi: 10.2174/1574887109666141216101630 – ident: ref_36 doi: 10.3390/nu12072141 – ident: ref_16 doi: 10.3390/jcm10091877 – volume: 11 start-page: 607 year: 2020 ident: ref_25 article-title: Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity publication-title: Front. Endocrinol. doi: 10.3389/fendo.2020.00607 – volume: 12 start-page: 60 year: 2020 ident: ref_4 article-title: NAFLD as a continuum: From obesity to metabolic syndrome and diabetes publication-title: Diabetol. Metab. Syndr. doi: 10.1186/s13098-020-00570-y – volume: 42 start-page: 1365 year: 2019 ident: ref_23 article-title: Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: Systematic review and consensus statement from the Italian Society of Endocrinology (SIE) publication-title: J. Endocrinol. Investig. doi: 10.1007/s40618-019-01061-2 – volume: 5 start-page: 16 year: 2020 ident: ref_5 article-title: Epidemiology of non-alcoholic and alcoholic fatty liver diseases publication-title: Transl. Gastroenterol. Hepatol. doi: 10.21037/tgh.2019.09.08 – volume: 11 start-page: 24084 year: 2021 ident: ref_9 article-title: A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight publication-title: Sci. Rep. doi: 10.1038/s41598-021-03583-3 – volume: 156 start-page: 1264 year: 2019 ident: ref_17 article-title: Noninvasive Assessment of Liver Disease in Patients with Nonalcoholic Fatty Liver Disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.12.036 – volume: 21 start-page: e13024 year: 2020 ident: ref_24 article-title: Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature publication-title: Obes. Rev. doi: 10.1111/obr.13024 – ident: ref_15 doi: 10.1186/1471-230X-6-33 – ident: ref_35 doi: 10.3390/nu13061804 – volume: 11 start-page: 199 year: 1992 ident: ref_29 article-title: Bioelectrical Impedance Analysis: A Review of Principles and Applications publication-title: J. Am. Coll. Nutr. doi: 10.1080/07315724.1992.12098245 – volume: 64 start-page: 1388 year: 2016 ident: ref_11 article-title: EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.11.004 – volume: 14 start-page: 222 year: 2021 ident: ref_20 article-title: Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO) European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis publication-title: Obes. Facts doi: 10.1159/000515381 – volume: 36 start-page: 15 year: 1990 ident: ref_30 article-title: Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints publication-title: Clin. Chem. doi: 10.1093/clinchem/36.1.15 – ident: ref_3 doi: 10.3390/ijms21165888 – volume: 19 start-page: 563 year: 2009 ident: ref_27 article-title: Adherence to the Mediterranean diet and risk of metabolic syndrome and its components publication-title: Nutr. Metab. Cardiovasc. Dis. doi: 10.1016/j.numecd.2008.10.007 |
| SSID | ssj0000070763 |
| Score | 2.4636948 |
| Snippet | Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on... |
| SourceID | pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 825 |
| SubjectTerms | Alcohol bioelectrical impedance blood Blood cholesterol blood glucose Body composition Body mass index Calories Causes of Cholesterol Complications and side effects Control Diabetes diastolic blood pressure Diet Diet therapy Diet, Ketogenic elasticity imaging techniques Electrodes Fatty liver Health aspects High density lipoprotein high density lipoprotein cholesterol Humans insulin Insulin Resistance Intervention Ketogenic diet liver Liver diseases low density lipoprotein cholesterol Low-calorie diet Meals Metabolic syndrome Non-alcoholic Fatty Liver Disease - diet therapy Nutrition research nutritional intervention Obesity Obesity - complications Outpatient care facilities Overweight Overweight - complications Physiological aspects Prospective Studies Questionnaires Risk factors thyroid hormones Triglycerides Viral infections Vitamin D Vitamin D deficiency waist circumference Weight control weight loss |
| Title | The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36839183 https://www.proquest.com/docview/2779613578 https://www.proquest.com/docview/2780066566 https://www.proquest.com/docview/3040398270 https://pubmed.ncbi.nlm.nih.gov/PMC9962649 |
| Volume | 15 |
| WOSCitedRecordID | wos000941012400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2072-6643 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000070763 issn: 2072-6643 databaseCode: M~E dateStart: 20090101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 2072-6643 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000070763 issn: 2072-6643 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2072-6643 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000070763 issn: 2072-6643 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2072-6643 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000070763 issn: 2072-6643 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELbolgMXXuURKNUgENBD1Dxt54SW7VagLssKVdVyimLHEUHglM0uaG8c-BP8PX4JYyebNgi4cEkOnjhO_HkezuQbQh6riHIpfe5KXpgSZlHkikhQN_EKmSEEVB4IW2yCTad8Pk9m7YZb3aZVbnSiVdR5Jc0e-UHAWIKmBwH2_Oyza6pGma-rbQmNLbJtmMqiAdl-MZ7O3na7LJbNhoYNL2mI8f2BXqELZKosxz1L9Ls-vmCQ-smSF6zP0bX_Hfd1crX1O2HYAOUGuaT0TbIz1Bhzf1rDE7CZoHaLfYd8R-xAQ2tcQ1XA2ATwYHh965_ffsCpWqxhUn11R5lJ31NwrJYV4rCUcFiqJTw7nYyOD_eh0jAxWR_Q_OoEpQZUUx9sr0Pbu8pBrOGNzc2298h0Dm2pglvk5Gh8MnrpttUaXBl7dOkmImHC9xkV6HSqwCswEMwCDHZjTxnOnYJKX4QJV2gSJapZVCxZ7olciTjzwiK8TQa60uouAV_mfsw9QT2ZRQpDMl5wj8tCMZFkQZE7ZH8zcalsmcxNQY2PKUY0ZpLT80l2yKNO9qzh7_ij1FMz_6lZ1NiTzNp_E3A8hh4rHaKfFcToSqLkbk8SF6PsN29QkLbKoE7PIeCQh12zudIkuGlVrYwMt1_BKP27TIiDxRcYMM8hdxpQds8UUvR0UT07hPXg2gkYGvF-iy7fWzpxjHjRK07u_Xvo98mVAP07m7BOd8lguVipB-Sy_LIs68Ue2WJzZo98r12DeJ69ej179wsaLDxb |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEB6VggQX_sqPocAgfnuwurbjXfuAUJS0apUQOERVbpZ3vRZBYJfEocqNAy_BQ_BSPAmzayetEXDrgfNONpvNzDczu7PfADzVHR4p5UWuinLTwqzTcWVHcjdmuUpJBXTmS9tsQoxG0WQSv9uAH6u3MKascoWJFqizUpkz8l1fiJhcDynY6-PPrukaZW5XVy00arUY6OUJpWzzV4d9-n-f-f7-3rh34DZdBVwVMl65sYyF9DzBJQVH2mc5JSypT0lZyLThhsm58mQQR5qgWxEckAGkGZOZlmHKgjygaS_ARYJxYSrIxESsj3QsdQ4PahLUIIjZbrGgeMu0dA5bbu938D_j_dqVmWdc3f61_2yTrsPVJqbGbm0EN2BDFzdhq1ukVflpic_RVrna64Mt-EZ2gTVl8xzLHPfM4QQazuL5z6_f8UjPljgsT9xeakoTNQ50VZKNTRX2p7rCl0fD3qC_g2WBQ1PRgvUzLpwWSBD8wc7atbPrDOUS39q6c_sdaZFh04bhFozPYztuw2ZRFvouoKcyL4yY5EylHU3pZpRHLFK5FjJO_TxzYGelJ4lqWNpNs5CPCWVrRqeSU51y4Mla9rjmJvmj1AujbokBLJpJpc27C1qPof5KuhRD-iGFySS53ZIkoFHt4ZXSJQ3QzZNTjXPg8XrYfNIU7xW6XBiZyN7wcf53mYAWSxvoC-bAndoG1r8p4BTFk-txQLSsYy1gKNLbI8X0vaVKp2yeIv743r-X_gguH4zfDJPh4WhwH674FMfawny-DZvVbKEfwCX1pZrOZw-twSMk52w7vwDjwJDY |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VFiEuvMojUGAQzx6srF9r-4BQlDQiSgg5VFU5Wd71Wk0Fdkkcqtw48Cf4KfwdfgmzayetEXDrgfNONpvNN6_d2W8AnimPh1LaoSXDTLcw8zxLeIJbEctkQhBQqSNMs4lgPA4PD6PJBvxYvYXRZZUrm2gMdVpIfUbedoIgItdDAGtndVnEpNd_c_LZ0h2k9E3rqp1GBZGhWp5S-jZ_PejRf_3ccfp7-923Vt1hwJI-46UViSgQth1wQYGSclhGyUviUILmM6V5YjIubeFGoSIzLsk0kDIkKROpEn7C3MylaS_BFkXkHqnY1mTwbvJhfcBjiHS4W1Gium7E2vmCoi_d4NlvOMHfXcE5X9is0zzn-PrX_-MtuwHX6mgbO5V63IQNld-C7U6elMWnJb5AU_9qLha24RtpDFZkznMsMtzTxxao2YznP79-xwM1W-KoOLW6iS5aVDhUZUHaN5XYm6oSXx2MusPeLhY5jnStC1YPvHCaIxnnYzNrx8yuUhRLfG8q0s13JHmKdYOG27B_EdtxBzbzIlf3AG2Z2n7IBGcy8RQlomEWslBmKhBR4mRpC3ZXmIllzd-u24h8jCmP0_iKz_DVgqdr2ZOKteSPUi819GJtymgmmdQvMmg9mhQs7hCsHZ8CaJLcaUiSCZLN4RUA49oEzuMz9LXgyXpYf1KX9eWqWGiZ0Nz9cf53GZcWSxvoBKwFdyt9WP8ml1N8T06pBUFDU9YCmjy9OZJPjwyJOuX5lAtE9_-99MdwhVQmHg3Gwwdw1aEA11Ts8x3YLGcL9RAuyy_ldD57VGs_QnzByvMLpnybJw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Effects+of+Eight+Weeks%E2%80%99+Very+Low-Calorie+Ketogenic+Diet+%28VLCKD%29+on+Liver+Health+in+Subjects+Affected+by+Overweight+and+Obesity&rft.jtitle=Nutrients&rft.au=Rinaldi%2C+Roberta&rft.au=De+Nucci%2C+Sara&rft.au=Castellana%2C+Fabio&rft.au=Di+Chito%2C+Martina&rft.date=2023-02-06&rft.issn=2072-6643&rft.eissn=2072-6643&rft.volume=15&rft.issue=4&rft.spage=825&rft_id=info:doi/10.3390%2Fnu15040825&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_nu15040825 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6643&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6643&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6643&client=summon |